You just read:

Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma

News provided by

Mylan N.V.

Apr 10, 2018, 07:30 ET